Our results suggest suggested that Pin1 could be a potent therapeutic target in cervical cancer treatment, and we believe that KPT-6566 has good prospects for the treatment of cervical cancer in combination with anti-tumour drugs. This evidence concerns the gene PIN1 and cervical carcinoma.